CONTRAVE
- Product NDC
- 50090-2868
- 11-digit product format
- 500902868
- Labeler code
- 50090
- Product ID
- 50090-2868_c5a82f8e-c627-4d42-8046-47c94ed56884
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- naltrexone hydrochloride and bupropion hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- NDA200063
- Marketing category
- NDA
- Marketing start
- 2014-09-10
- Marketing end
- 0000-00-00
- Substance
- NALTREXONE HYDROCHLORIDE; BUPROPION HYDROCHLORIDE
- Active strength
- 8 mg/1; mg/1
- Pharmacologic classes
- Opioid Antagonist [EPC],Opioid Antagonists [MoA],Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record